Key result
A novel fully automated digital immunoassay for cardiac troponin I achieved a limit of detection of 0.01 ng/L and detected significantly higher concentrations in heart failure patients.
A novel ultrasensitive digital immunoassay for cTnI demonstrates a 2-log increase in sensitivity compared to contemporary assays, enabling detection in all healthy individuals and showing correlation with heart failure severity.
No takes yet. Share an insight, caveat, or question.
May enable routine troponin monitoring; leaves open clinical utility pending larger validation studies.
Jarolı́m et al. (2015) studied Healthy individuals and heart failure. Fully automated ultrasensitive digital immunoassay for cardiac troponin I was evaluated on Analytical performance (limit of detection, limit of quantification, total CV) and cTnI concentrations. A novel fully automated digital immunoassay for cardiac troponin I achieved a limit of detection of 0.01 ng/L and detected significantly higher concentrations in heart failure patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: